Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses (Tables)

v3.19.3.a.u2
Accrued Expenses (Tables)
9 Months Ended
Dec. 31, 2019
Payables and Accruals [Abstract]  
Accrued expenses
 

 

 December 31,

 

 

 March 31,

 

 

 

 2019

 

 

 2019

 

 

 

 

 

 

 

 

      clinical trial, development and related expenses  $876,600   $1,067,600 
 Accrued compensation   -    439,200 
 Accrued professional services   66,800    172,100 
 All other   7,900    6,700 
   $951,300   $1,685,600